Grant Details
| Grant Number: | 5R50CA211115-06 Interpret this number |
| Primary Investigator: | Bowles, Erin |
| Organization: | Kaiser Foundation Research Institute |
| Project Title: | Group Health Cancer Research Program Research Specialist Award |
| Fiscal Year: | 2021 |
Abstract
Project Summary/Abstract The goal of this application is to support Erin Bowles, MPH, as a Senior Research Associate at Group Health Research Institute. She supports the Cancer Research Group on multiple NCI-funded projects under the direction of Diana Buist, PhD. Ms. Bowles is an accomplished epidemiologic cancer scientist in areas such as breast cancer screening and treatment. Her work is primarily funded by the National Cancer Institute. Group Health is a learning healthcare system, giving her work the potential to be translated and disseminated into clinical practice. This Research Specialist Award would provide her with 5 years of funding during which she would commit to working on NCI-funded projects such as the Breast Cancer Surveillance Consortium and Cancer Research Network. These projects have had measurable impacts on healthcare and health outcomes in the US, such as contributing to national breast cancer screening guideline development and providing population-based estimates of cancer treatment outcomes beyond results from clinical trials. On these projects, Ms. Bowles will fill various roles including site PI, project/data manager, clinical liaison, mammographic density reader, statistical analyst, grant writer, publication author, and cancer epidemiologist. She will actively work to ensure project results are broadly disseminated to clinical practice.
Publications
Response to Yu, Wang, and Ge.
Authors: Sampathkumar Y. , Zakaria Z. , O'Connell K. , Bhimani J. , Blinder V.S. , Burganowski R. , Ergas I.J. , Gallagher G.B. , Griggs J.J. , Heon N. , et al. .
Source: Journal Of The National Cancer Institute, 2026-07-01 00:00:00.0; 118(7), p. 1332-1333.
PMID: 42157410
Related Citations
The landscape of chemotherapy modifications among women treated for stage I-IIIA breast cancer.
Authors: Bhimani J. , O'Connell K. , Blinder V.S. , Burganowski R. , Ergas I.J. , Gallagher G.B. , Griggs J.J. , Heon N. , Jinna S. , Kolevska T. , et al. .
Source: Cancer, 2026-03-15 00:00:00.0; 132(6), p. e70318.
PMID: 41808563
Related Citations
Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer.
Authors: Sampathkumar Y. , Zakaria Z. , O'Connell K. , Bhimani J. , Blinder V.S. , Burganowski R. , Ergas I.J. , Gallagher G.B. , Griggs J.J. , Heon N. , et al. .
Source: Journal Of The National Cancer Institute, 2026-03-04 00:00:00.0; , .
EPub date: 2026-03-04 00:00:00.0.
PMID: 41782330
Related Citations
Initial chemotherapy dose reductions and subsequent treatment delivery in stage I-IIIA breast cancer.
Authors: Monroy-Iglesias M.J. , O'Connell K. , Bhimani J. , Blinder V.S. , Burganowski-Doud R.P. , Ergas I.J. , Gallagher G.B. , Griggs J.J. , Heon N. , Kolevska T. , et al. .
Source: Cancer, 2026-03-01 00:00:00.0; 132(5), p. e70294.
PMID: 41732900
Related Citations
Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer.
Authors: Aiello Bowles E.J. , O'Connell K. , Bhimani J. , Gallagher G.B. , Blinder V.S. , Doud R.B. , Ergas I.J. , Griggs J.J. , Heon N. , Kolevska T. , et al. .
Source: Journal Of The National Cancer Institute, 2026-02-01 00:00:00.0; 118(2), p. 307-315.
PMID: 41183113
Related Citations
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast Cancer.
Authors: Sampathkumar Y. , Zakaria Z. , O'Connell K. , Bhimani J. , Blinder V.S. , Burganowski R. , Ergas I.J. , Gallagher G.B. , Griggs J.J. , Heon N. , et al. .
Source: Jco Oncology Practice, 2025-12-11 00:00:00.0; , p. OP2500086.
EPub date: 2025-12-11 00:00:00.0.
PMID: 41380106
Related Citations
Evaluation of methods to identify chemotherapy-related hematologic toxicities in real-world settings.
Authors: Wang P. , O'Connell K. , Bhimani J. , Blinder V. , Burganowski R. , Ergas I.J. , Gallagher G.B. , Griggs J.J. , Heon N. , Kolevska T. , et al. .
Source: International Journal Of Cancer, 2025-11-28 00:00:00.0; , .
EPub date: 2025-11-28 00:00:00.0.
PMID: 41313142
Related Citations
Contralateral breast cancer after radiotherapy and hormone therapy in two cohorts of US breast cancer survivors.
Authors: Veiga L.H.S. , Gierach G.L. , Smith S.A. , Howell R.M. , Mille M.M. , Saha M. , Curtis R.E. , Ramin C. , Bodelon C. , Feigelson H.S. , et al. .
Source: British Journal Of Cancer, 2025-11-14 00:00:00.0; , .
EPub date: 2025-11-14 00:00:00.0.
PMID: 41238801
Related Citations
Understanding the association between body mass index and chemotherapy dose reductions in women treated for stage I-IIIA breast cancer.
Authors: Bhimani J. , O'Connell K. , Gallagher G.B. , Blinder V.S. , Burganowski R. , Ergas I.J. , Griggs J.J. , Heon N. , Jinna S. , Kolevska T. , et al. .
Source: Npj Breast Cancer, 2025-10-29 00:00:00.0; 11(1), p. 119.
EPub date: 2025-10-29 00:00:00.0.
PMID: 41162408
Related Citations
Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk.
Authors: Smith-Bindman R. , Alber S.A. , Kwan M.L. , Pequeno P. , Bolch W.E. , Bowles E.J.A. , Greenlee R.T. , Stout N.K. , Weinmann S. , Moy L.M. , et al. .
Source: The New England Journal Of Medicine, 2025-09-17 00:00:00.0; , .
EPub date: 2025-09-17 00:00:00.0.
PMID: 40961449
Related Citations
Patient characteristics associated with conventional schedule vs. dose dense chemotherapy in women with stage I-IIIA breast cancer.
Authors: Bhimani J. , Wang P. , Gallagher G.B. , O'Connell K. , Persaud S. , Blinder V.S. , Burganowski R. , Ergas I.J. , Griggs J.J. , Heon N. , et al. .
Source: Breast Cancer Research And Treatment, 2025-07-06 00:00:00.0; , .
EPub date: 2025-07-06 00:00:00.0.
PMID: 40618298
Related Citations
Patient factors and modifications to intended chemotherapy for women with Stages I-IIIA breast cancer.
Authors: Bhimani J. , Wang P. , Gallagher G.B. , O'Connell K. , Blinder V. , Burganowski R. , Ergas I.J. , Griggs J.J. , Heon N. , Kolevska T. , et al. .
Source: International Journal Of Cancer, 2025-06-02 00:00:00.0; , .
EPub date: 2025-06-02 00:00:00.0.
PMID: 40454906
Related Citations
Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study.
Authors: Wang P. , O'Connell K. , Bhimani J. , Blinder V. , Burganowski R. , Ergas I.J. , Gallagher G.B. , Griggs J.J. , Heon N. , Kolevska T. , et al. .
Source: Jco Clinical Cancer Informatics, 2025 Feb; 9, p. e2400231.
EPub date: 2025-02-14 00:00:00.0.
PMID: 39951671
Related Citations
Disparities in Standard-of-Care, Advanced, and Same-Day Diagnostic Services among Patients with Abnormal Screening Mammography.
Authors: Lawson M.B. , Zhu W. , Miglioretti D.L. , Onega T. , Henderson L.M. , Rauscher G.H. , Kerlikowske K. , Sprague B.L. , Bowles E.J.A. , O'Meara E.S. , et al. .
Source: Radiology, 2025 Feb; 314(2), p. e241673.
PMID: 39964269
Related Citations
Association Between False-Positive Results and Return to Screening Mammography in the Breast Cancer Surveillance Consortium Cohort.
Authors: Miglioretti D.L. , Abraham L. , Sprague B.L. , Lee C.I. , Bissell M.C.S. , Ho T.H. , Bowles E.J.A. , Henderson L.M. , Hubbard R.A. , Tosteson A.N.A. , et al. .
Source: Annals Of Internal Medicine, 2024-09-03 00:00:00.0; , .
EPub date: 2024-09-03 00:00:00.0.
PMID: 39222505
Related Citations
Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ from 2001 to 2018.
Authors: Bowles E.J.A. , Ramin C. , Vo J.B. , Feigelson H.S. , Gander J.C. , Veiga L.H.S. , Bodelon C. , Curtis R.E. , Brandt C. , de Gonzalez A.B. , et al. .
Source: Breast Cancer Research And Treatment, 2024-08-16 00:00:00.0; , .
EPub date: 2024-08-16 00:00:00.0.
PMID: 39148003
Related Citations
The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system.
Authors: Bhimani J. , O'Connell K. , Persaud S. , Blinder V. , Burganowski R.P. , Ergas I.J. , Gallagher G.B. , Griggs J.J. , Heon N. , Kolevska T. , et al. .
Source: Breast Cancer Research And Treatment, 2024-08-16 00:00:00.0; , .
EPub date: 2024-08-16 00:00:00.0.
PMID: 39150586
Related Citations
Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors.
Authors: Vo J.B. , Ramin C. , Veiga L.H.S. , Brandt C. , Curtis R.E. , Bodelon C. , Barac A. , Roger V.L. , Feigelson H.S. , Buist D.S.M. , et al. .
Source: Journal Of The National Cancer Institute, 2024-08-01 00:00:00.0; 116(8), p. 1384-1394.
PMID: 38718210
Related Citations
Patient characteristics associated with intended non-guideline chemotherapy in women with stage I-IIIA breast cancer.
Authors: Bhimani J. , O'Connell K. , Persaud S. , Blinder V. , Burganowski-Doud R.P. , Ergas I.J. , Gallagher G.B. , Griggs J.J. , Heon N. , Kolevska T. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2024-07-25 00:00:00.0; , .
EPub date: 2024-07-25 00:00:00.0.
PMID: 39051907
Related Citations
Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer.
Authors: Bhimani J. , O'Connell K. , Persaud S. , Blinder V. , Burganowski R. , Ergas I.J. , Foley M.J. , Gallagher G.B. , Griggs J.J. , Heon N. , et al. .
Source: International Journal Of Cancer, 2024-07-06 00:00:00.0; , .
EPub date: 2024-07-06 00:00:00.0.
PMID: 38970396
Related Citations
Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer.
Authors: Bhimani J. , O'Connell K. , Ergas I.J. , Foley M. , Gallagher G.B. , Griggs J.J. , Heon N. , Kolevska T. , Kotsurovskyy Y. , Kroenke C.H. , et al. .
Source: Jco Clinical Cancer Informatics, 2024 Apr; 8, p. e2300209.
PMID: 38635936
Related Citations
Temporal changes in mammographic breast density and breast cancer risk among women with benign breast disease.
Authors: Mullooly M. , Fan S. , Pfeiffer R.M. , Bowles E.A. , Duggan M.A. , Falk R.T. , Richert-Boe K. , Glass A.G. , Kimes T.M. , Figueroa J.D. , et al. .
Source: Breast Cancer Research : Bcr, 2024-03-26 00:00:00.0; 26(1), p. 52.
EPub date: 2024-03-26 00:00:00.0.
PMID: 38532516
Related Citations
Evaluation of algorithms using automated health plan data to identify breast cancer recurrences.
Authors: Aiello Bowles E.J. , Kroenke C.H. , Chubak J. , Bhimani J. , O'Connell K. , Brandzel S. , Valice E. , Doud R. , Theis M.K. , Roh J.M. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2023-12-13 00:00:00.0; , .
EPub date: 2023-12-13 00:00:00.0.
PMID: 38088912
Related Citations
Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic density: a cohort study.
Authors: Atakpa E.C. , Buist D.S.M. , Aiello Bowles E.J. , Cuzick J. , Brentnall A.R. .
Source: Breast Cancer Research : Bcr, 2023-11-24 00:00:00.0; 25(1), p. 147.
EPub date: 2023-11-24 00:00:00.0.
PMID: 38001476
Related Citations
Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system.
Authors: Kantor E.D. , O'Connell K. , Ergas I.J. , Valice E. , Roh J.M. , Bhimani J. , Heon N. , Griggs J.J. , Lee J. , Bowles E.J. , et al. .
Source: Breast Cancer Research And Treatment, 2023-11-04 00:00:00.0; , .
EPub date: 2023-11-04 00:00:00.0.
PMID: 37923962
Related Citations
Digital mammography and digital breast tomosynthesis for detecting invasive lobular and ductal carcinoma.
Authors: Onega T. , Abraham L. , Miglioretti D.L. , Lee C.I. , Henderson L.M. , Kerlikowske K. , Tosteson A.N.A. , Weaver D. , Sprague B.L. , Bowles E.J.A. , et al. .
Source: Breast Cancer Research And Treatment, 2023-09-11 00:00:00.0; , .
EPub date: 2023-09-11 00:00:00.0.
PMID: 37697031
Related Citations
Impact of Surveillance Mammography Intervals Less Than One Year on Performance Measures in Women With a Personal History of Breast Cancer.
Authors: Lee J.M. , Ichikawa L.E. , Wernli K.J. , Bowles E.J.A. , Specht J.M. , Kerlikowske K. , Miglioretti D.L. , Lowry K.P. , Tosteson A.N.A. , Stout N.K. , et al. .
Source: Korean Journal Of Radiology, 2023 Aug; 24(8), p. 729-738.
PMID: 37500574
Related Citations
Racial and ethnic variation in diagnostic mammography performance among women reporting a breast lump.
Authors: Nyante S.J. , Abraham L. , Aiello Bowles E.J. , Lee C.I. , Kerlikowske K. , Miglioretti D.L. , Sprague B.L. , Henderson L.M. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2023-07-13 00:00:00.0; , .
EPub date: 2023-07-13 00:00:00.0.
PMID: 37440458
Related Citations
Impact of BMI on Prevalence of Dense Breasts by Race and Ethnicity.
Authors: Kerlikowske K. , Bissell M.C.S. , Sprague B.L. , Tice J.A. , Tossas K.Y. , Bowles E.J.A. , Ho T.H. , Keegan T.H.M. , Miglioretti D.L. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2023-06-07 00:00:00.0; , p. OF1-OF7.
EPub date: 2023-06-07 00:00:00.0.
PMID: 37284771
Related Citations
Digital Breast Tomosynthesis versus Digital Mammography Screening Performance on Successive Screening Rounds from the Breast Cancer Surveillance Consortium.
Authors: Sprague B.L. , Coley R.Y. , Lowry K.P. , Kerlikowske K. , Henderson L.M. , Su Y.R. , Lee C.I. , Onega T. , Bowles E.J.A. , Herschorn S.D. , et al. .
Source: Radiology, 2023 Jun; 307(5), p. e223142.
PMID: 37249433
Related Citations
Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort.
Authors: Ramin C. , Veiga L.H.S. , Vo J.B. , Curtis R.E. , Bodelon C. , Aiello Bowles E.J. , Buist D.S.M. , Weinmann S. , Feigelson H.S. , Gierach G.L. , et al. .
Source: Breast Cancer Research : Bcr, 2023-05-03 00:00:00.0; 25(1), p. 50.
EPub date: 2023-05-03 00:00:00.0.
PMID: 37138341
Related Citations
National Performance Benchmarks for Screening Digital Breast Tomosynthesis: Update from the Breast Cancer Surveillance Consortium.
Authors: Lee C.I. , Abraham L. , Miglioretti D.L. , Onega T. , Kerlikowske K. , Lee J.M. , Sprague B.L. , Tosteson A.N.A. , Rauscher G.H. , Bowles E.J.A. , et al. .
Source: Radiology, 2023-04-11 00:00:00.0; , p. 222499.
EPub date: 2023-04-11 00:00:00.0.
PMID: 37039687
Related Citations
Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status.
Authors: Lowry K.P. , Ichikawa L. , Hubbard R.A. , Buist D.S.M. , Bowles E.J.A. , Henderson L.M. , Kerlikowske K. , Specht J.M. , Sprague B.L. , Wernli K.J. , et al. .
Source: Cancer, 2023-02-15 00:00:00.0; , .
EPub date: 2023-02-15 00:00:00.0.
PMID: 36789739
Related Citations
Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency.
Authors: Sprague B.L. , Chen S. , Miglioretti D.L. , Gard C.C. , Tice J.A. , Hubbard R.A. , Aiello Bowles E.J. , Kaufman P.A. , Kerlikowske K. .
Source: Jama Network Open, 2023-02-01 00:00:00.0; 6(2), p. e230166.
EPub date: 2023-02-01 00:00:00.0.
PMID: 36808238
Related Citations
Performance of statistical and machine learning risk prediction models for surveillance benefits and failures in breast cancer survivors.
Authors: Su Y.R. , Buist D.S. , Lee J.M. , Ichikawa L. , Miglioretti D.L. , Aiello Bowles E.J. , Wernli K.J. , Kerlikowske K. , Tosteson A. , Lowry K.P. , et al. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2023-01-25 00:00:00.0; , .
EPub date: 2023-01-25 00:00:00.0.
PMID: 36697364
Related Citations
Medical imaging utilization and associated radiation exposure in children with down syndrome.
Authors: Marlow E.C. , Ducore J.M. , Kwan M.L. , Bowles E.J.A. , Greenlee R.T. , Pole J.D. , Rahm A.K. , Stout N.K. , Weinmann S. , Smith-Bindman R. , et al. .
Source: Plos One, 2023; 18(9), p. e0289957.
EPub date: 2023-09-06 00:00:00.0.
PMID: 37672503
Related Citations
Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort study.
Authors: Veiga L.H.S. , Vo J.B. , Curtis R.E. , Mille M.M. , Lee C. , Ramin C. , Bodelon C. , Aiello Bowles E.J. , Buist D.S.M. , Weinmann S. , et al. .
Source: The Lancet. Oncology, 2022-10-11 00:00:00.0; , .
EPub date: 2022-10-11 00:00:00.0.
PMID: 36240805
Related Citations
Correction to: The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systems.
Authors: Ramin C. , Gierach G.L. , Abubakar M. , Veiga L.H.S. , Vo J.B. , Curtis R.E. , Bowles E.J.A. , Feigelson H.S. , Buist D.S.M. , de Gonzalez A.B. , et al. .
Source: Cancer Causes & Control : Ccc, 2022-10-10 00:00:00.0; , .
EPub date: 2022-10-10 00:00:00.0.
PMID: 36214934
Related Citations
Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race and Ethnicity.
Authors: Lawson M.B. , Bissell M.C.S. , Miglioretti D.L. , Eavey J. , Chapman C.H. , Mandelblatt J.S. , Onega T. , Henderson L.M. , Rauscher G.H. , Kerlikowske K. , et al. .
Source: Jama Oncology, 2022-08-01 00:00:00.0; 8(8), p. 1115-1126.
PMID: 35737381
Related Citations
Accuracy of tumor registry versus pharmacy dispensings for breast cancer adjuvant endocrine therapy.
Authors: Haas C.B. , Bowles E.J.A. , Lee J.M. , Specht J. , Buist D.S.M. .
Source: Cancer Causes & Control : Ccc, 2022-07-07 00:00:00.0; , .
EPub date: 2022-07-07 00:00:00.0.
PMID: 35796846
Related Citations
The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systems.
Authors: Ramin C. , Gierach G.L. , Abubakar M. , Veiga L.H.S. , Vo J.B. , Curtis R.E. , Bowles E.J.A. , Feigelson H.S. , Buist D.S.M. , Berrington de Gonzalez A. , et al. .
Source: Cancer Causes & Control : Ccc, 2022 Jul; 33(7), p. 1019-1023.
EPub date: 2022-05-18 00:00:00.0.
PMID: 35583697
Related Citations
Diagnostic Mammography Performance across Racial and Ethnic Groups in a National Network of Community-Based Breast Imaging Facilities.
Authors: Nyante S.J. , Abraham L. , Aiello Bowles E.J. , Lee C.I. , Kerlikowske K. , Miglioretti D.L. , Sprague B.L. , Henderson L.M. , Breast Cancer Surveillance Consortium .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2022-07-01 00:00:00.0; 31(7), p. 1324-1333.
PMID: 35712862
Related Citations
Patient and tumour characteristics of screening-age adults diagnosed with screen-detected versus symptomatic colon cancer.
Authors: Sarma E.A. , Thompson M.J. , Bowles E.J.A. , Burnett-Hartman A.N. , Hubbard R.A. , Yu O. , Chubak J. .
Source: Colorectal Disease : The Official Journal Of The Association Of Coloproctology Of Great Britain And Ireland, 2022-06-23 00:00:00.0; , .
EPub date: 2022-06-23 00:00:00.0.
PMID: 35739634
Related Citations
Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer.
Authors: Abubakar M. , Mullooly M. , Nyante S. , Pfeiffer R.M. , Aiello Bowles E.J. , Cora R. , Bodelon C. , Butler E. , Butcher D. , Sternberg L. , et al. .
Source: Jnci Cancer Spectrum, 2022-05-02 00:00:00.0; 6(3), .
PMID: 35583138
Related Citations
Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer.
Authors: Abubakar M. , Mullooly M. , Nyante S. , Pfeiffer R.M. , Aiello Bowles E.J. , Cora R. , Bodelon C. , Butler E. , Butcher D. , Sternberg L. , et al. .
Source: Jnci Cancer Spectrum, 2022-05-02 00:00:00.0; 6(3), .
PMID: 35583138
Related Citations
Endocrine therapy initiation among women with stage I-III invasive, hormone receptor-positive breast cancer from 2001-2016.
Authors: Bowles E.J.A. , Ramin C. , Buist D.S.M. , Feigelson H.S. , Weinmann S. , Veiga L.H.S. , Bodelon C. , Curtis R.E. , Vo J.B. , Berrington de Gonzalez A. , et al. .
Source: Breast Cancer Research And Treatment, 2022-03-11 00:00:00.0; , .
EPub date: 2022-03-11 00:00:00.0.
PMID: 35275285
Related Citations
Quantifying cancer risk from exposures to medical imaging in the Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging (RIC) Study: research methods and cohort profile.
Authors: Kwan M.L. , Miglioretti D.L. , Bowles E.J.A. , Weinmann S. , Greenlee R.T. , Stout N.K. , Rahm A.K. , Alber S.A. , Pequeno P. , Moy L.M. , et al. .
Source: Cancer Causes & Control : Ccc, 2022-02-02 00:00:00.0; , .
EPub date: 2022-02-02 00:00:00.0.
PMID: 35107724
Related Citations
Positive predictive value and sensitivity of ICD-9-CM codes for identifying pediatric leukemia.
Authors: Weinmann S. , Francisco M.C. , Kwan M.L. , Bowles E.J.A. , Rahm A.K. , Greenlee R.T. , Stout N.K. , Pole J.D. , Kushi L.H. , Smith-Bindman R. , et al. .
Source: Pediatric Blood & Cancer, 2022 02; 69(2), p. e29383.
EPub date: 2021-11-13 00:00:00.0.
PMID: 34773439
Related Citations
Using Protection Motivation Theory to Predict Intentions for Breast Cancer Risk Management: Intervention Mechanisms from a Randomized Controlled Trial.
Authors: Conley C.C. , Wernli K.J. , Knerr S. , Li T. , Leppig K. , Ehrlich K. , Farrell D. , Gao H. , Bowles E.J.A. , Graham A.L. , et al. .
Source: Journal Of Cancer Education : The Official Journal Of The American Association For Cancer Education, 2021-11-23 00:00:00.0; , .
EPub date: 2021-11-23 00:00:00.0.
PMID: 34813048
Related Citations
Effect of a Randomized Trial of a Web-Based Intervention on Patient-Provider Communication About Breast Density.
Authors: Bowles E.J.A. , O'Neill S.C. , Li T. , Knerr S. , Mandelblatt J.S. , Schwartz M.D. , Jayasekera J. , Leppig K. , Ehrlich K. , Farrell D. , et al. .
Source: Journal Of Women's Health (2002), 2021 11; 30(11), p. 1529-1537.
EPub date: 2021-09-28 00:00:00.0.
PMID: 34582721
Related Citations